FDA Accepts NEVCORE Innovations's PMTA Application for CLEW Nicotine Pouches

Jun.11.2024
FDA Accepts NEVCORE Innovations's PMTA Application for CLEW Nicotine Pouches
FDA accepts NEVCORE Innovations' PMTA for CLEW nicotine pouches with various flavors and nicotine concentrations, promising top-quality experience.

According to a recent report from Reuters, the Food and Drug Administration (FDA) has accepted NEVCORE Innovations' application for premarket tobacco product approval (PMTA) for its oral nicotine pouch brand, CLEW.


CLEW nicotine pouches come in flavors such as mint, fruit, and tobacco, with nicotine concentrations ranging from 3mg to 20mg.


The company's founder and chairman, Mr. Nutesh Singla, emphasized:


The core concept of CLEW nicotine pouch products is our unwavering commitment to providing consumers with an unparalleled experience by combining cutting-edge technology and the finest ingredients. CLEW nicotine pouches are developed in top laboratories in the United States, containing pharmaceutical-grade nicotine and carefully selected flavorings to ensure a satisfying experience with every use.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Brazilian Government: Social Media and E-Commerce Platforms Must Remove Vape-Related Content Within 48 Hours
Brazilian Government: Social Media and E-Commerce Platforms Must Remove Vape-Related Content Within 48 Hours
Brazil’s government has given social media and e-commerce platforms 48 hours to take down content and offers related to e-cigarettes. The order, issued by the National Council to Combat Piracy and Intellectual Property Crimes (CNCP), is part of a nationwide crackdown on illegal online sales and advertising of vaping products. Companies must also file compliance reports within ten business days or face penalties.
Aug.25 by 2FIRSTS.ai
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
HM Revenue & Customs (HMRC) has officially confirmed that the UK will implement a Vaping Products Duty (VPD) and Vaping Duty Stamps (VDS) scheme from October 1, 2026. The duty will apply to all vaping liquids at a flat rate of £2.20 per 10ml. Businesses must register for approval starting April 1, 2026. The stamps scheme will take effect in October 2026 with a six-month grace period, after which, from April 2027, unstamped products will be prohibited from sale.
Oct.02 by 2FIRSTS.ai
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
The U.S. International Trade Commission (USITC) has instituted an investigation titled Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) based on a complaint by JUUL Labs, Inc. JUUL alleges that NJOY, its parent and affiliates at Altria Group, infringed U.S. Patent No. 12,156,533 through the importation and sale of certain ENDS devices, cartridges, and components. JUUL seeks a limited exclusion order and cease-and-desist orders. Respondents must answer within 20 d
Sep.11 by 2FIRSTS.ai
Company | JTI Cambodia Awarded “Gold Tax Compliance Certificate”
Company | JTI Cambodia Awarded “Gold Tax Compliance Certificate”
Japan Tobacco International (Cambodia) Co., Ltd. has received the “Gold Tax Compliance Certificate,” valid for 2026–2027, marking the company’s third consecutive recognition.
Sep.05 by 2FIRSTS.ai
Malaysia Seizes 300,000 Smuggled Vapes and Components, Suspected for Singapore Market, Labeled with “Salthub”
Malaysia Seizes 300,000 Smuggled Vapes and Components, Suspected for Singapore Market, Labeled with “Salthub”
Malaysian Customs in Port Klang seized about 300,000 smuggled e-cigarettes and components. The shipment, disguised as furniture and labeled "Salthub," lacked required health warnings. It was likely smuggled to Singapore by road. The UNODC has warned that Malaysia is a key transit point for drug and e-cigarette smuggling to Southeast Asia.
Sep.03 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai